Lista de obras - Giulio Fracasso - Dominio Público Uruguay

A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia.

artículo científico publicado en 2018

A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin

artículo científico publicado en 2004

A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer.

artículo científico publicado en 2013

An electrochemiluminescence-supramolecular approach to sarcosine detection for early diagnosis of prostate cancer.

artículo científico publicado en 2015

Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer

scientific article published on 02 June 2020

Anti-tumor effects of toxins targeted to the prostate specific membrane antigen

artículo científico publicado en 2002

Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA).

artículo científico publicado en 2014

Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part I

artículo científico publicado en 2020

Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen

artículo científico publicado en 2020

Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen

artículo científico publicado en 2013

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody

artículo científico publicado en 2014

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen

artículo científico publicado en 2015

Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy

scientific article published on 20 October 2020

Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies

artículo científico publicado en 2000

Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.

artículo científico publicado en 2016

Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging

artículo científico publicado en 2016

Gangliosides act as onconeural antigens in paraneoplastic neuropathies

artículo científico publicado en 2004

Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin

artículo científico publicado en 1995

Highly sensitive electrochemiluminescence detection of a prostate cancer biomarker

artículo científico publicado en 2017

Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones

article published in 2001

Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements

artículo científico publicado en 2015

In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.

artículo científico publicado en 2016

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

artículo científico publicado en 2018

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma

artículo científico publicado en 2011

Laser generated gold nanocorals with broadband plasmon absorption for photothermal applications

artículo científico publicado en 2015

Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells

artículo científico publicado en 2017

Magneto-plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging

artículo científico publicado en 2014

N-terminal deletion affects catalytic activity of saporin toxin

artículo científico publicado en 2006

Nanoaggregates of iron poly-oxo-clusters obtained by laser ablation in aqueous solution of phosphonates

artículo científico publicado en 2018

PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models

artículo científico publicado en 2014

Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection

artículo científico publicado en 2015

Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin

artículo científico publicado en 2001

Plasmonic nanostructures for SERRS multiplexed identification of tumor-associated antigens

artículo científico publicado en 2012

Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".

artículo científico publicado en 2016

Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase

artículo científico publicado en 2004

SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells

artículo científico publicado en 2020

Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness.

artículo científico publicado en 2016

Simple and Rapid Non-Enzymatic Procedure Allows the Isolation of Structurally Preserved Connective Tissue Micro-Fragments Enriched with SVF

artículo científico publicado en 2020

Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems

artículo científico publicado en 2013

Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts

artículo científico publicado en 2014

The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways.

artículo científico publicado en 2009

Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.

artículo científico publicado en 2017

Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation

article published in 2011

Lista de obras de Giulio Fracasso

A SERRS/MRI multimodal contrast agent based on naked Au nanoparticles functionalized with a Gd(iii) loaded PEG polymer for tumor imaging and localized hyperthermia.

A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin

A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer.

An electrochemiluminescence-supramolecular approach to sarcosine detection for early diagnosis of prostate cancer.

Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer

Anti-tumor effects of toxins targeted to the prostate specific membrane antigen

Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA).

Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy-Part I

Development of 177Lu-scFvD2B as a Potential Immunotheranostic Agent for Tumors Overexpressing the Prostate Specific Membrane Antigen

Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen

Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody

Effect of radiochemical modification on biodistribution of scFvD2B antibody fragment recognising prostate specific membrane antigen

Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy

Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies

Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.

Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging

Gangliosides act as onconeural antigens in paraneoplastic neuropathies

Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin

Highly sensitive electrochemiluminescence detection of a prostate cancer biomarker

Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones

Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements

In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma

Laser generated gold nanocorals with broadband plasmon absorption for photothermal applications

Liposomes derivatized with multimeric copies of KCCYSL peptide as targeting agents for HER-2-overexpressing tumor cells

Magneto-plasmonic Au-Fe alloy nanoparticles designed for multimodal SERS-MRI-CT imaging

N-terminal deletion affects catalytic activity of saporin toxin

Nanoaggregates of iron poly-oxo-clusters obtained by laser ablation in aqueous solution of phosphonates

PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models

Parallel optical read-out of micromechanical pillars applied to prostate specific membrane antigen detection

Pharmacokinetics of intrathecal transferrin-ricin a chain immunotoxin

Plasmonic nanostructures for SERRS multiplexed identification of tumor-associated antigens

Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo".

Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase

SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells

Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness.

Simple and Rapid Non-Enzymatic Procedure Allows the Isolation of Structurally Preserved Connective Tissue Micro-Fragments Enriched with SVF

Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems

Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts

The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways.

Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.

Top-down synthesis of multifunctional iron oxide nanoparticles for macrophage labelling and manipulation